← All stocks

Theravance Biopharma, Inc.

TBPH Net selling
CIK 0001583107 #2645 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$8.68M
$1.23M on a plan · $1.66M straight out of an exercise
Sold at will
$5.79M
3 of 17 sales
Net
−$8.68M
−$5.79M against sales at will

By person

13 insiders · 17 transactions
26.5×

Rick E Winningham holds 26.5 times base salary in stock. $27.79M of shares against $1.05M in salary for 2025.

Salary from the company's own proxy. The shares are what Rick E Winningham last reported holding, valued at $17.00, the price COM was last bought or sold at on the open market here, on 1 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Samaha Eli
10% owner
$5.79M (3)
−$5.79M
9,174,453
$155.98M
−3.5%
BROSHY ERAN
Director
$1.66M (5) scheduled
−$1.66M
44,703
$760.00K
−63.5%
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
$1.23M (9) scheduled
−$1.23M
226,790
$3.86M
−30.6%
Winningham Rick E
CHIEF EXECUTIVE OFFICER
1,634,422
$27.79M
−10.6%
Grimaud Brett A.
SVP, GEN COUNSEL AND SECRETARY
355,168
$6.04M
+3.7%
Sawaf Aziz
SVP & CHIEF FINANCIAL OFFICER
336,841
$5.73M
+4.8%
Miller Aine
SVP, DEV & HEAD OF IRE OFFICE
189,826
$3.23M
+18.2%
MITCHELL DEAN J
Director
97,213
$1.65M
+20.7%
Smaldone Alsup Laurie
Director
80,989
$1.38M
+25.9%
O'Connor Donal
Director
80,213
$1.36M
+26.2%
PAKIANATHAN DEEPIKA
Director
64,074
$1.09M
+35.1%
GRAY SUSANNAH
Director
48,146
$818.54K
+52.9%
Grant Jeremy T
Director
32,954
$560.26K
+47.7%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Insider
Date
Role
Action
Shares
Price
Amount
Samaha Eli
1 Jul 2026
10% owner
Sell indirect
37,799
$17.00
$642.63K
Samaha Eli
30 Jun 2026
10% owner
Sell indirect
25,027
$17.13
$428.79K
Samaha Eli
29 Jun 2026
10% owner
Sell indirect
273,871
$17.23
$4.72M

What was left out

Form 4 filings counted 36
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 1
Joint filings 0
Sales on a Rule 10b5-1 plan 9
Sales straight out of an exercise 5
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 593,187
History held since 22 Nov 2016